Literature DB >> 33021632

Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.

López-Cortés Rubén1, Muinelo-Romay Laura2, Fernández-Briera Almudena3, Gil Martín Emilio4.   

Abstract

The α(1,6)fucose residue attached to the N-glycoprotein core is suspected to play an essential role in the progression of several types of cancer. Lectins remain the first choice for probing glycan modifications, although they may lack specificity. Thus, efforts have been made to identify new lectins with a narrower core fucose (CF) detection profile. Here, we present a comparison of the classical Aleuria aurantia lectin (AAL), Lens culinaris agglutinin (LCA) and Aspergillus oryzae lectin (AOL) with the newer Pholiota squarrosa lectin (PhoSL), which has been described as being specific for core fucosylated N-glycans. To this end, we studied the binding profiles of the four lectins using mammalian glycan arrays from the Consortium of Functional Glycomics. To validate their glycan specificity, we probed AOL, LCA and PhoSL in western-blot assays using protein extracts from eight common colorectal cancer (CRC) lines and colorectal biopsies from a small cohort of patients with CRC. The results showed that (i) LCA and PhoSL were the most specific lectins for detecting the presence of CF in a concentration-dependent manner; (ii) PhoSL exhibited the highest N-glycan sequence restriction, with preferential binding to core fucosylated paucimannosidic-type N-glycans, (iii) the recognition ability of PhoSL was highly influenced by the presence of terminal N-acetyl-lactosamine; (iv) LCA bound to paucimannosidic, bi-antennary and tri-antennary core fucosylated N-glycans and (v) AOL and AAL exhibited broader specificity towards fucosylation. Together, our results support the choice of LCA as the most appropriate lectin for CF detection, as validated in protein extracts from CRC cell lines and tissue specimens from patients with CRC.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  core fucosylation; fucose lectins; glycan array; lactosamine lectins; specific recognition

Mesh:

Substances:

Year:  2021        PMID: 33021632      PMCID: PMC8921745          DOI: 10.1093/glycob/cwaa093

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  118 in total

1.  β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer.

Authors:  Chia-Hua Chen; Shui-Hua Wang; Chiung-Hui Liu; Yi-Ling Wu; Wei-Jen Wang; John Huang; Ji-Shiang Hung; I-Rue Lai; Jin-Tung Liang; Min-Chuan Huang
Journal:  Carcinogenesis       Date:  2014-01-08       Impact factor: 4.944

2.  Purification of the glycoprotein lectin from the broad bean (Vicia faba) and a comparison of its properties with lectins of similar specificity.

Authors:  A K Allen; N N Desai; A Neuberger
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells.

Authors:  Calvin McCarter; Doron Kletter; Huiyuan Tang; Katie Partyka; Yinjiao Ma; Sudhir Singh; Jessica Yadav; Marshall Bern; Brian B Haab
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

4.  Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance.

Authors:  Scott H Millen; Daniel M Lewallen; Andrew B Herr; Suri S Iyer; Alison A Weiss
Journal:  Biochemistry       Date:  2010-07-20       Impact factor: 3.162

5.  Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking α1,3-arm GlcNAc.

Authors:  Qiang Yang; Roushu Zhang; Hui Cai; Lai-Xi Wang
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

6.  Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.

Authors:  Guoling Huang; Zhi Li; Yuqing Li; Gang Liu; Shijie Sun; Jianguo Gu; Akihiko Kameyama; Wenzhe Li; Weijie Dong
Journal:  Biochem J       Date:  2020-03-27       Impact factor: 3.857

7.  Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer.

Authors:  Laura Muinelo-Romay; Susana Villar-Portela; Elisa Cuevas; Emilio Gil-Martín; Almudena Fernández-Briera
Journal:  BMC Cancer       Date:  2011-12-07       Impact factor: 4.430

8.  Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.

Authors:  P J Johnson; T C Poon; N M Hjelm; C S Ho; S K Ho; C Welby; D Stevenson; T Patel; R Parekh; R R Townsend
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29.

Authors:  Philip Noble; Ian Spendlove; Stephen Harding; Tina Parsons; Lindy G Durrant
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

10.  FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.

Authors:  Cheng-Fen Tu; Meng-Ying Wu; Yuh-Charn Lin; Reiji Kannagi; Ruey-Bing Yang
Journal:  Breast Cancer Res       Date:  2017-10-05       Impact factor: 6.466

View more
  3 in total

Review 1.  Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.

Authors:  Yuna Guo; Wenshuang Jia; Jingru Yang; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

2.  Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model.

Authors:  Rubén López-Cortés; Laura Muinelo-Romay; Almudena Fernández-Briera; Emilio Gil-Martín
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

Review 3.  Fucosylation in Urological Cancers.

Authors:  Kazutoshi Fujita; Koji Hatano; Mamoru Hashimoto; Eisuke Tomiyama; Eiji Miyoshi; Norio Nonomura; Hirotsugu Uemura
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.